Want to see HK:1246 full AI Analyst Report?
1246 Stock Chart & Stats
HK$0.02
HK$0.00(0.00%)
At close: 4:00 PM EDT
HK$0.02
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.02 - HK$0.02
Previous CloseN/A
Volume3.03M
Average Volume (3M)0.00
Market Cap
HK$28.52M
Enterprise ValueHK$1.30K
Total Cash (Recent Filing)HK$1.08M
Total Debt (Recent Filing)HK$842.17M
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Nov 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding1,358,000,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)-1.31
Price to Sales (P/S)1.52
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Healthcare Sector FocusBoill Healthcare Holdings' focus on healthcare services and property development positions it in a growing industry with long-term demand, providing potential for sustainable revenue streams.
Strategic PartnershipsStrategic partnerships enhance service offerings and expand the property portfolio, potentially driving long-term growth and competitive advantage in the healthcare sector.
Healthcare Property DevelopmentSpecializing in healthcare property development allows Boill to cater to a niche market, potentially offering stable demand and revenue opportunities as healthcare infrastructure needs grow.
Bears Say
High LeverageHigh leverage and negative equity position present significant financial risk, potentially limiting the company's ability to invest in growth opportunities and increasing vulnerability to economic downturns.
Negative Cash FlowZero cash flow generation suggests liquidity issues, hindering the company's capacity to fund operations and service debt, impacting long-term financial stability.
Declining RevenueDeclining revenue and persistent losses indicate operational inefficiencies and challenges in maintaining market share, posing risks to long-term profitability and growth.
Boill Healthcare Holdings Limited News
1246 FAQ
What was Boill Healthcare Holdings Limited’s price range in the past 12 months?
Boill Healthcare Holdings Limited lowest stock price was HK$0.02 and its highest was HK$0.02 in the past 12 months.
What is Boill Healthcare Holdings Limited’s market cap?
Boill Healthcare Holdings Limited’s market cap is HK$28.52M.
When is Boill Healthcare Holdings Limited’s upcoming earnings report date?
Boill Healthcare Holdings Limited’s upcoming earnings report date is Nov 20, 2026 which is in 105 days.
How were Boill Healthcare Holdings Limited’s earnings last quarter?
Boill Healthcare Holdings Limited released its earnings results on Jun 30, 2026. The company reported -HK$0.117 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Boill Healthcare Holdings Limited overvalued?
According to Wall Street analysts Boill Healthcare Holdings Limited’s price is currently Overvalued.
Does Boill Healthcare Holdings Limited pay dividends?
Boill Healthcare Holdings Limited does not currently pay dividends.
What is Boill Healthcare Holdings Limited’s EPS estimate?
Boill Healthcare Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Boill Healthcare Holdings Limited have?
Boill Healthcare Holdings Limited has 1,358,000,000 shares outstanding.
What happened to Boill Healthcare Holdings Limited’s price movement after its last earnings report?
Boill Healthcare Holdings Limited reported an EPS of -HK$0.117 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Boill Healthcare Holdings Limited?
Currently, no hedge funds are holding shares in HK:1246
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Boill Healthcare Holdings Limited
Boill Healthcare Holdings Limited functions as an investment holding company, primarily engaged in foundation piling contracts within Hong Kong and mainland China. Its operations are diversified across four main segments: Property Development, Healthcare Holiday Resort Development and Operation, Foundation Piling, and Securities Investment. The company's activities include developing and selling real estate, offering property management solutions, participating in securities trading and investments, and providing services such as elderly care, healthcare, and leisure experiences. It was formerly named Ngai Shun Holdings Limited, adopting its current name in September 2017. The company's headquarters are located in Central, Hong Kong.
Technical Analysis
Modern Land (China) Co., Ltd.
―
Jingrui Holdings Ltd.
―
Sunshine 100 China Holdings Ltd.
―
Xinming China Holdings Limited
―
Sanxun Holdings Group Limited
―